Published by
@ShahidNShah
@ShahidNShah
Industry Groups Question Aspects of CDRH’s AI/ML-Based SaMD Framework
Feedback on the US Food and Drug Administration’s (FDA) proposed regulatory framework for artificial intelligence- (AI) and machine learning- (ML) based software as a medical device (SaMD) underscores the uncertain environment for developing such products.
Continue reading at raps.org
Make faster decisions with community advice
- AMA recommends ways to optimize EHRs for better diabetes detection
- How To Teach Kids (Digital) Health Literacy?
- Complex Pediatric Home Health and the Potential of Interoperability
- Data analytics holds promise of dramatically improving outcomes for patients with autoimmune disease
- Q&A: Microsoft Healthcare’s Peter Lee on How the Cloud Will Transform Health IT
Next Article
-
AMA recommends ways to optimize EHRs for better diabetes detection
The American Medical Association said health care providers can improve detection of patients at risk for type 2 diabetes by optimizing clinical decision support, patient portal and population health …
Posted Jun 12, 2019
